COTINGA PHARMACEUTICALS INC. ("COT") [formerly CRITICAL OUTCOME TECHNOLOGIES INC. ("COT")] BULLETIN TYPE: Name Change BULLETIN DATE: January 8, 2018 TSX Venture Tier 2 Company
Pursuant to a resolution passed by shareholders December 20, 2017, the Company has changed its name as follows. There is no consolidation of capital.
Effective at the opening January 10, 2018, the common shares of Cotinga Pharmaceuticals Inc. will commence trading on TSX Venture Exchange, and the common shares of Critical Outcome Technologies Inc. will be delisted. The Company is classified as a 'Biotechnology/Biopharmaceutical' company.
Capitalization: unlimited shares with no par value of which 16,686,968 shares are issued and outstanding Escrow: 0 shares
Transfer Agent: Computershare Trust Company of Canada Trading Symbol: COT (unchanged) CUSIP Number: 22164W105 (new) ________________________________________
|
|